DLL4 and neoplasm: Such a potent increase in tumor cell apoptosis by the combination treatment might be due to direct cytotoxic effects of irinotecan against highly proliferating tumor cells together with the anti-angiogenic effects of mABL001, a bispecific antibody binding against dual antigens, VEGF, and mouse DLL4.